Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/ana.25783 http://scihub22266oqcxt.onion/10.1002/ana.25783 32418288!7276848!32418288     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32418288.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Ann+Neurol 2020 ; 88 (2): 423-427 Nephropedia Template TP {{tp|p=32418288|t=2020. Steroid-Responsive Encephalitis in Coronavirus Disease 2019 |pdf=|usr=}}{{32418288}} gab.com Text Steroid-Responsive Encephalitis in Coronavirus Disease 2019 JO: Ann Neurol http://www.kidney.de/pget.php?&tw=1&pmid=32418288 #FOAvip Coronavirus disease 2019 (COVID-19) infection has the potential for targeting the central nervous system, and several neurological symptoms have been described in patients with severe respiratory distress. Here, we described the case of a 60-year-old patient with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection but only mild respiratory abnormalities who developed an akinetic mutism attributable to encephalitis. Magnetic resonance imaging was negative, whereas electroencephalography showed generalized theta slowing. Cerebrospinal fluid analyses during the acute stage were negative for SARS-CoV-2, positive for pleocytosis and hyperproteinorrachia, and showed increased interleukin-8 and tumor necrosis factor-alpha concentrations. Other infectious or autoimmune disorders were excluded. A progressive clinical improvement along with a reduction of cerebrospinal fluid parameters was observed after high-dose steroid treatment, thus arguing for an inflammatory-mediated brain involvement related to COVID-19. ANN NEUROL 2020;88:423-427. Twit Text FOAVip Steroid-Responsive Encephalitis in Coronavirus Disease 2019 ????Ann Neurol http://www.kidney.de/pget.php?&tw=1&pmid=32418288 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32418288 #FOAvip English Wikipedia <ref>{{Cite pmid|32418288}}</ref> Steroid-Responsive Encephalitis in Coronavirus Disease 2019 #MMPMID32418288 Pilotto A; Odolini S; Masciocchi S; Comelli A; Volonghi I; Gazzina S; Nocivelli S; Pezzini A; Foca E; Caruso A; Leonardi M; Pasolini MP; Gasparotti R; Castelli F; Ashton NJ; Blennow K; Zetterberg H; Padovani A Ann Neurol 2020[Aug]; 88 (2): 423-427 PMID32418288show ga Coronavirus disease 2019 (COVID-19) infection has the potential for targeting the central nervous system, and several neurological symptoms have been described in patients with severe respiratory distress. Here, we described the case of a 60-year-old patient with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection but only mild respiratory abnormalities who developed an akinetic mutism attributable to encephalitis. Magnetic resonance imaging was negative, whereas electroencephalography showed generalized theta slowing. Cerebrospinal fluid analyses during the acute stage were negative for SARS-CoV-2, positive for pleocytosis and hyperproteinorrachia, and showed increased interleukin-8 and tumor necrosis factor-alpha concentrations. Other infectious or autoimmune disorders were excluded. A progressive clinical improvement along with a reduction of cerebrospinal fluid parameters was observed after high-dose steroid treatment, thus arguing for an inflammatory-mediated brain involvement related to COVID-19. ANN NEUROL 2020;88:423-427. |Akinetic Mutism/*physiopathology[MESH] |Antiviral Agents/*therapeutic use[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Coronavirus Infections/cerebrospinal fluid/complications/*drug therapy/physiopathology[MESH] |Drug Combinations[MESH] |Electroencephalography[MESH] |Encephalitis/cerebrospinal fluid/complications/*drug therapy/physiopathology[MESH] |Glucocorticoids/*therapeutic use[MESH] |Humans[MESH] |Hydroxychloroquine/therapeutic use[MESH] |Interleukin-6/cerebrospinal fluid[MESH] |Interleukin-8/cerebrospinal fluid[MESH] |Lopinavir/therapeutic use[MESH] |Magnetic Resonance Imaging[MESH] |Male[MESH] |Methylprednisolone/*therapeutic use[MESH] |Middle Aged[MESH] |Pandemics[MESH] |Pneumonia, Viral/cerebrospinal fluid/complications/*drug therapy/physiopathology[MESH] |Ritonavir/therapeutic use[MESH] |SARS-CoV-2[MESH] |Treatment Outcome[MESH] |Tumor Necrosis Factor-alpha/cerebrospinal fluid[MESH]Steroid-Responsive Encephalitis in Coronavirus Disease 2019 (epmc).pdf DeepDyve Pubget Overpricing